REGENTIS BIOMATERIALS LTD. business relationships
Companies named in REGENTIS BIOMATERIALS LTD.’s 20-F filed 2026-02-24, and public companies whose annual reports name REGENTIS BIOMATERIALS LTD.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 3.5 / 10
- AI naming
- <1 / 100 Top 86% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in REGENTIS BIOMATERIALS LTD.’s annual report 2
“purchase certain services from Baxter in connection with Teva's supply of Tisseel under the Agreement for manufacturing of” SEC filing
“| | | 4. | | In 2019, a disagreement arose between the Company and CSL Behring GmbH (the "CSL") as to whether certain unshipped minimum purchase commitments for fibrinogen from 2018 to 2020 are to be paid by the Company pursuant to a Framework Supply Agreement dated March 8, 2016 (the "Framework Sup...” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.